ProCap Acquisition Corp (PCAP) vs Translational Development Acquisition Corp. (TDAC)

A side-by-side comparison of ProCap Acquisition Corp and Translational Development Acquisition Corp. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — PCAP vs TDAC

growth of $100 · dividends reinvested · last 1y
PCAP -2.8% (-2.8%/yr)TDAC +5.8% (+5.8%/yr)TDAC compounded faster over this window
95100105110Start $1002026$97$106
PCAP TDAC

PCAP vs TDAC: by the numbers

  • •TDAC is the larger company ($266M vs $264M market cap).
  • •PCAP trades at the lower trailing earnings multiple (31.55 vs 42.00 P/E), one valuation lens rather than an overall verdict.

Metrics side by side

Valuation

MetricPCAPTDAC
P/E ratio31.5542.00
P/B ratio1.061.78

Profitability

MetricPCAPTDAC
Gross margin0.00%0.00%
Operating margin0.00%0.00%
Net margin0.00%0.00%
ROE3.49%3.70%
ROIC-0.23%-0.84%

Frequently asked

Which has the lower trailing P/E, PCAP or TDAC?
PCAP has the lower trailing P/E: PCAP trades at 31.55 and TDAC at 42.00. P/E is one valuation measure and does not by itself establish which business is cheaper.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.